QQ客服 官方微博 反馈留言

	Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance
	Xu, Haiyan; Yang, Guangjian; Yang, Lu; Yang, Yaning; Ma, Di; Li, Junling; Hao, Xuezhi; Xing, Puyuan; Wang, Yan
	2019
卷号	10期号:5页码:1096-1102
关键词	ALK crizotinib non-small cell lung cancer prognosis resistance
ISSN号	1759-7706
DOI	10.1111/1759-7714.13050
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6343166
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Xu, Haiyan,Yang, Guangjian,Yang, Lu,et al. Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance[J],2019,10(5):1096-1102.
APA	Xu, Haiyan.,Yang, Guangjian.,Yang, Lu.,Yang, Yaning.,Ma, Di.,...&Wang, Yan.(2019).Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance.,10(5),1096-1102.
MLA	Xu, Haiyan,et al."Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance".10.5(2019):1096-1102.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。